A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma
Seung Ah Choi(Seoul National University Children's Hospital), Seung‐Ki Kim(Seoul National University Children's Hospital), Ji Hoon Phi(Seoul National University Children's Hospital), Chang Sik Lee(Chong Kun Dang Bio (South Korea)), Pil Ae Kwak(Seoul National University Hospital), Ju‐Hee Lee(Dongguk University), Kyu‐Chang Wang(National Cancer Center), Chul‐Kee Park(Seoul National University Hospital), Ji Yeoun Lee(Seoul National University)
Cited by 14
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma
|Journal of Clinical Oncology|2013|488
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
Spatiotemporal Evolution of the Primary Glioblastoma Genome
|Cancer Cell|2015|320